Hyun Yong Koh

Hyun Yong Koh

Auto-generated profile, based on publicly available information

Hyun Yong Koh

Department of Pediatrics, Texas Children's Hospital, Houston

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2020 in JMIR Medical Informatics
Verified
Journal Article
Open access
Seung Won LeeSeung Won Lee
Seung Won Lee
Woon Tak YuhWoon Tak Yuh
Woon Tak Yuh
JYJee Myung Yang
Jee Myung Yang
YCYoon-Sik Cho
Yoon-Sik Cho
IYIn kyung Yoo
In kyung Yoo
DYDong Keon Yon
Dong Keon Yon
Background: Evidence regarding the effectiveness of contact tracing of COVID-19 and the related social distancing is limited and inconclusive. Objective: This study aims to investigate the epidemiological characteristics of SARS-CoV-2 transmission in South Korea and evaluate whether a social distancing campaign is effective in mitigating the spread of COVID-19. Methods: We used contract tracing data to investigate the epidemic characteristics of SARS-CoV-2 transmission in South Korea and evaluate whether a social distancing campaign was effective in mitigating the spread of COVID-19. We calculated the mortality rate for COVID-19 by infection type (cluster vs noncluster) and tested whether new confirmed COVID-19 trends changed after a social distancing campaign. Results: There were 2537 patients with confirmed COVID-19 who completed the epidemiologic survey: 1305 (51.4%) cluster cases and 1232 (48.6%) noncluster cases. The mortality rate was significantly higher in cluster cases linked to medical facilities (11/143, 7.70% vs 5/1232, 0.41%; adjusted percentage difference 7.99%; 95% CI 5.83 to 10.14) and long-term care facilities (19/221, 8.60% vs 5/1232, 0.41%; adjusted percentage difference 7.56%; 95% CI 5.66 to 9.47) than in noncluster cases. The change in trends of newly confirmed COVID-19 cases before and after the social distancing campaign was significantly negative in the entire cohort (adjusted trend difference –2.28; 95% CI –3.88 to –0.68) and the cluster infection group (adjusted trend difference –0.96; 95% CI –1.83 to –0.09). Conclusions: In a nationwide contact tracing study in South Korea, COVID-19 linked to medical and long-term care facilities significantly increased the risk of mortality compared to noncluster COVID-19. A social distancing campaign decreased the spread of COVID-19 in South Korea and differentially affected cluster infections of SARS-CoV-2.

28 June 2021 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
HKHyun Yong Koh
Hyun Yong Koh
JJJaeson Jang
Jaeson Jang
SJSang Hyeon Ju
Sang Hyeon Ju
RKRyunhee Kim
Ryunhee Kim
GCGyu‐Bon Cho
Gyu‐Bon Cho
JLJeong Ho Lee
Jeong Ho Lee

10 January 2022 in Genetics in Medicine
Verified
Journal Article
Open access
HKHyun Yong Koh
Hyun Yong Koh
AHAlireza Haghighi
Alireza Haghighi
CKChristine Keywan
Christine Keywan
SASanda Alexandrescu
Sanda Alexandrescu
EPErin Plews-Ogan
Erin Plews-Ogan
RGRichard D. Goldstein
Richard D. Goldstein
To evaluate genetic contributions to sudden unexpected death in pediatrics (SUDP). We phenotyped and performed exome sequencing on 352 SUDP cases. We analyzed for variants in 294 “SUDP genes” with mechanisms plausibly related to sudden death. In a subset of 73 cases with parental data (trios), we performed exome-wide analyses. We conducted cohort-wide burden analyses. In total, we identified likely contributory variants in 37/352 probands (11%). Analysis of SUDP genes identified pathogenic/likely pathogenic (P/LP) variants in 12/352 cases (SCN1A, DEPDC5[2], GABRG2, SCN5A[2], TTN[2], MYBPC3, PLN, TNNI3, and PDHA1) and variants of uncertain significance-favor pathogenic (VUS-FP) in 17/352. Exome-wide analyses of the 73 cases with family data additionally identified 4 de novo P/LP variants (SCN1A[2], ANKRD1, and BRPF1) and 4 de novo VUS-FP. Comparing cases vs. controls, we demonstrated an excess burden of rare damaging SUDP gene variants (OR 2.94; 95% CI, 2.37-4.21) and of de novo variants exome-wide in the subset of 73 with trio data (OR 3.13; 95% CI, 1.91-5.16). We provide strong evidence for a role of genetic factors in SUDP, involving both candidate genes and novel genes for SUDP, and expand phenotypes of disease genes not previously associated with sudden death.

23 October 2024 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
JKJuliet K. Knowles
Juliet K. Knowles
AWAaron E. L. Warren
Aaron E. L. Warren
IMIsmail S. Mohamed
Ismail S. Mohamed
CSCarl E. Stafstrom
Carl E. Stafstrom
HKHyun Yong Koh
Hyun Yong Koh
ZGZachary M. Grinspan
Zachary M. Grinspan
Objective: Lennox‐Gastaut syndrome (LGS) is a severe, childhood‐onset epilepsy that is typically refractory to treatment. We surveyed the current landscape of LGS treatment, aiming to identify challenges to the development of efficacious therapies, and to articulate corresponding priorities toward clinical trials that improve outcomes. Methods: The LGS Special Interest Group of the Pediatric Epilepsy Research Consortium integrated evidence from the literature and expert opinion, into a narrative review. Results: We provide an overview of approved and emerging medical, dietary, surgical and neuromodulation approaches for LGS. We note that quality of care could be improved by standardizing LGS treatment based on expert consensus and empirical data. Whereas LGS natural history is incompletely understood, prospective studies and use of large retrospective datasets to understand LGS across the lifespan would enable clinical trials that address these dynamics. Recent discoveries related to LGS pathophysiology should enable development of disease‐modifying therapies, which are currently lacking. Finally, clinical trials have focused chiefly on seizures involving “drops,” but should incorporate additional patient‐centered outcomes, using emerging measures adapted to people with LGS. Interpretation: Clinicians and researchers should enact these priorities, with the goal of patient‐centered clinical trials that are tailored to LGS pathophysiology and natural history.

1 January 2019 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
SLShinhae Lee
Shinhae Lee
HKHyun Yong Koh
Hyun Yong Koh
DYDong Keon Yon
Dong Keon Yon
Seung Won LeeSeung Won Lee
Seung Won Lee
EHEunkyo Ha
Eunkyo Ha
MHMan Yong Han
Man Yong Han
Lee S, et al. Allergy Asthma Immunol Res. 2019 Jul;11(4):572-582. https://doi.org/10.4168/aair.2019.11.4.572

18 September 2025 in Epilepsia Open
Verified
Journal Article
Open access
MCMichelle Y. Chiu
Michelle Y. Chiu
CKCynthia G. Keator
Cynthia G. Keator
AWAaron E. L. Warren
Aaron E. L. Warren
JKJuliet K. Knowles
Juliet K. Knowles
Debopam SamantaDebopam Samanta
Debopam Samanta
CKCemal Karakas
Cemal Karakas
Objective: The objective of this study is to characterize contemporary surgical management practices and factors influencing surgical decision‐making in the management of Lennox–Gastaut Syndrome (LGS) across pediatric epilepsy centers in the United States. Methods: A 45‐item cross‐sectional survey was developed and distributed to Pediatric Epilepsy Research Consortium centers. Domains included institutional demographics, surgical evaluation timing and goals, presurgical workup, procedural utilization and outcomes, and barriers to surgery. Descriptive statistics and thematic analysis were performed. Results: Thirty‐two pediatric epilepsy centers participated (38% response), the majority comprising pediatric epileptologists at Level 4 National Association of Epilepsy Centers. Most centers (66%) considered surgery after failure of 3–4 antiseizure medications. Presurgical workup typically included brain magnetic resonance imaging (MRI), long‐term electroencephalography (EEG) monitoring, and neuropsychological assessment, while use of functional imaging, magnetoencephalography, and intracranial EEG varied considerably. All centers offered vagus nerve stimulation and corpus callosotomy; 80%–90% offered resection, hemispherectomy, responsive neurostimulation (RNS); 60%–65% offered deep brain stimulation (DBS) and laser ablation. Among centers offering RNS, half targeted thalamic structures exclusively, and the remainder targeted cortical or combined cortical‐thalamic structures; the centromedian nucleus was the preferred thalamic target for RNS and DBS. Surgical decision‐making was influenced by patient characteristics, procedural considerations, and systemic factors. Seizure frequency, family preference, and multidisciplinary input were highly rated across all interventions. Etiology was critical for resection and hemispherectomy, while financial constraints, insurance barriers, and the need for future neuroimaging impacted neuromodulation selection. Scenario‐specific trends included less frequent consideration of DBS and RNS in children under five years, less use of hemispherectomy in older children, preference for corpus callosotomy in children with predominantly drop seizures, and procedural selection based on MRI findings. Significance: Substantial variability exists in the surgical management of LGS. These findings highlight critical opportunities to harmonize practices, reduce disparities, and guide comparative effectiveness research to optimize outcomes. Plain Language Summary: Lennox–Gastaut Syndrome (LGS) is a severe form of epilepsy that may require surgery when medications are not effective. This study found that surgical care for LGS varies widely across pediatric epilepsy centers in the United States, including when surgery is recommended, how patients are evaluated, and which procedures are available. Newer approaches such as brain stimulation are being used more often, although access remains inconsistent. These findings highlight the need for clearer treatment pathways to ensure that children with LGS have equitable access to the best possible care.